VIVANI MEDICAL INC (VANI:NASDAQ)
$1.26 -0.03 (-2.3256%)
Analysed VIVANI MEDICAL INC (VANI:NASDAQ) News Sources
Vivani Medical, Inc. Announces Closing of Common Stock Offering
27-01-2026
yahoo.com
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
29-01-2026
yahoo.com
Insiders Are Still Scooping Up Under Armour and WR Berkley Shares
31-01-2026
247wallst.com
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
26-03-2026
yahoo.com
Vivani Medical: Q4 Earnings Snapshot
26-03-2026
yahoo.com
Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright
01-04-2026
yahoo.com
Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?
03-04-2026
yahoo.com
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
13-05-2026
yahoo.com
Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation
15-05-2026
yahoo.com
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
28-05-2026
yahoo.com
What is the current price of VIVANI MEDICAL INC (VANI:NASDAQ)?
The current price of VIVANI MEDICAL INC (VANI:NASDAQ) is $1.26.
VIVANI MEDICAL INC (VANI:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIVANI MEDICAL INC (VANI:NASDAQ) since the previous trading day is $-0.03.
VIVANI MEDICAL INC (VANI:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIVANI MEDICAL INC (VANI:NASDAQ) since the previous trading day is -2.3256%.
What is the most recent average sentiment score for VIVANI MEDICAL INC (VANI:NASDAQ)?
The most recent average sentiment score for VIVANI MEDICAL INC (VANI:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for VIVANI MEDICAL INC (VANI:NASDAQ)?
The most recent sentiment for VIVANI MEDICAL INC (VANI:NASDAQ) is .
SEC-8K** Filing Available For VIVANI MEDICAL INC (VANI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.